Compare Stocks: IART, HAE, LIVN, and ITGR

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HAE Haemonetics	$103.00 +0.1%	$88.26	$47.31 ▼ $109.57	$4.68B	0.54	759,131 shs	423,611 shs
IART Integra LifeSciences	$16.72	$17.76	$8.70 ▼ $20.49	$1.30B	1.21	598,184 shs	674,345 shs
ITGR Integer	$126.40 -0.1%	$111.69	$62.00 ▼ $126.80	$4.30B	0.62	834,926 shs	1.61 million shs
LIVN LivaNova	$81.92	$80.67	$48.82 ▼ $85.76	$4.51B	0.87	597,815 shs	334,166 shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HAE Haemonetics	0.00%	+0.27%	+17.71%	+30.43%	+89.54%
IART Integra LifeSciences	0.00%	-1.18%	-3.07%	-6.59%	+4.57%
ITGR Integer	0.00%	+0.86%	+1.07%	+34.68%	+18.34%
LIVN LivaNova	0.00%	+2.64%	+7.48%	+6.16%	+41.31%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HAE Haemonetics	$103.00 +0.1%	$88.26	$47.31 ▼ $109.57	$4.68B	0.54	759,131 shs	423,611 shs
IART Integra LifeSciences	$16.72	$17.76	$8.70 ▼ $20.49	$1.30B	1.21	598,184 shs	674,345 shs
ITGR Integer	$126.40 -0.1%	$111.69	$62.00 ▼ $126.80	$4.30B	0.62	834,926 shs	1.61 million shs
LIVN LivaNova	$81.92	$80.67	$48.82 ▼ $85.76	$4.51B	0.87	597,815 shs	334,166 shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HAE Haemonetics	0.00%	+0.27%	+17.71%	+30.43%	+89.54%
IART Integra LifeSciences	0.00%	-1.18%	-3.07%	-6.59%	+4.57%
ITGR Integer	0.00%	+0.86%	+1.07%	+34.68%	+18.34%
LIVN LivaNova	0.00%	+2.64%	+7.48%	+6.16%	+41.31%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HAE Haemonetics	2.73	Moderate Buy	$99.78	-3.13% Downside
IART Integra LifeSciences	1.88	Reduce	$18.86	12.78% Upside
ITGR Integer	2.07	Hold	$109.86	-13.09% Downside
LIVN LivaNova	2.55	Moderate Buy	$84.13	2.69% Upside

Current Analyst Ratings Breakdown

Latest IART, HAE, LIVN, and ITGR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/3/2026	HAE Haemonetics	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$105.00 ➝ $125.00
9/2/2026	LIVN LivaNova	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$87.00 ➝ $90.00
8/21/2026	HAE Haemonetics	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$96.00 ➝ $119.00
8/19/2026	HAE Haemonetics	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$95.00 ➝ $118.00
8/19/2026	LIVN LivaNova	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/18/2026	LIVN LivaNova	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C) ➝ Hold (C+)
8/18/2026	HAE Haemonetics	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$96.00 ➝ $110.00
8/14/2026	IART Integra LifeSciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/13/2026	ITGR Integer	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold
8/11/2026	HAE Haemonetics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
8/7/2026	HAE Haemonetics	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform	$105.00

(Data available from 9/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HAE Haemonetics	$1.33B	3.51	$7.58 per share	13.58	$17.14 per share	6.01
IART Integra LifeSciences	$1.64B	0.80	$4.22 per share	3.96	$13.40 per share	1.25
ITGR Integer	$1.85B	2.32	$10.36 per share	12.20	$49.85 per share	2.54
LIVN LivaNova	$1.39B	3.25	$4.84 per share	16.94	$21.98 per share	3.73

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HAE Haemonetics	$97.31M	$2.04	50.49	17.98	2.06	7.12%	27.55%	9.65%	11/5/2026 (Estimated)
IART Integra LifeSciences	-$516.47M	-$0.09	N/A	6.51	0.86	-0.44%	18.30%	5.30%	10/29/2026 (Estimated)
ITGR Integer	$102.81M	$3.66	34.54	18.81	2.39	6.97%	12.79%	6.48%	10/22/2026 (Estimated)
LIVN LivaNova	-$242.47M	$3.38	24.24	19.79	N/A	12.82%	16.35%	7.76%	11/4/2026 (Estimated)

Latest IART, HAE, LIVN, and ITGR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q1 2027	HAE Haemonetics	$1.08	$1.14	+$0.06	$0.72	$327.86 million	$339.38 million
8/6/2026	Q2 2026	LIVN LivaNova	$1.09	$1.26	+$0.17	$1.93	$380.50 million	$390.59 million
8/3/2026	Q2 2026	ITGR Integer	$1.38	$1.60	+$0.22	$0.69	$451.07 million	$464.11 million
7/29/2026	Q2 2026	IART Integra LifeSciences	$0.4805	$0.56	+$0.0795	$0.06	$417.54 million	$418.76 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
HAE Haemonetics	N/A	N/A	N/A	N/A	N/A
IART Integra LifeSciences	N/A	N/A	N/A	N/A	N/A
ITGR Integer	N/A	N/A	N/A	N/A	N/A
LIVN LivaNova	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HAE Haemonetics	1.40	3.08	1.91
IART Integra LifeSciences	1.75	3.60	2.11
ITGR Integer	0.75	3.73	2.41
LIVN LivaNova	0.22	1.45	1.21

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
HAE Haemonetics	99.67%
IART Integra LifeSciences	84.78%
ITGR Integer	99.29%
LIVN LivaNova	97.64%

Insider Ownership

Company	Insider Ownership
HAE Haemonetics	2.07%
IART Integra LifeSciences	3.84%
ITGR Integer	1.10%
LIVN LivaNova	0.35%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
HAE Haemonetics	3,009	45.50 million	44.56 million	Optionable
IART Integra LifeSciences	4,427	77.77 million	74.79 million	Optionable
ITGR Integer	11,000	33.99 million	33.62 million	Optionable
LIVN LivaNova	3,300	55.09 million	54.90 million	Optionable

IART, HAE, LIVN, and ITGR Headlines

Recent News About These Companies

LivaNova to Present at Morgan Stanley and Baird Healthcare Conferences in September

September 4, 2026 | uk.finance.yahoo.com

Insider Selling: LivaNova (NASDAQ:LIVN) Director Sells $131,538.00 in Stock

September 3, 2026 | insidertrades.com

Francesco Bianchi Sells 1,650 Shares of LivaNova (NASDAQ:LIVN) Stock

September 2, 2026 | marketbeat.com

Wellington Management Group LLP Sells 151,482 Shares of LivaNova PLC $LIVN

September 1, 2026 | marketbeat.com

LivaNova (NASDAQ:LIVN) Shares Cross Above 50-Day Moving Average - Here's Why

August 29, 2026 | marketbeat.com

LivaNova: Careful About The Valuation And Upside

August 25, 2026 | seekingalpha.com

LivaNova (NASDAQ:LIVN) Downgraded by Zacks Research to "Hold"

August 21, 2026 | marketbeat.com

LivaNova (NASDAQ:LIVN) Gains Attention After Strong Results

August 20, 2026 | kalkinemedia.comK

LivaNova PLC (NASDAQ:LIVN) Given Consensus Rating of "Moderate Buy" by Analysts

August 20, 2026 | marketbeat.com

LivaNova PLC $LIVN Stake Lessened by Bank of America Corp DE

August 15, 2026 | marketbeat.com

LivaNova (LIVN) Q2 2026 Earnings Call Transcript

August 12, 2026 | finance.yahoo.com

LivaNova PLC $LIVN Shares Purchased by Quantinno Capital Management LP

August 9, 2026 | marketbeat.com

LivaNova Q2 Earnings & Revenues Beat Estimates, '26 Outlook Raised

August 6, 2026 | zacks.com

LivaNova raises guidance on Q2 beats

August 6, 2026 | massdevice.com

LivaNova PLC 2026 Q2 - Results - Earnings Call Presentation

August 5, 2026 | seekingalpha.com

LivaNova PLC (LIVN) Q2 2026 Earnings Call Transcript

August 5, 2026 | seekingalpha.com

LivaNova (LIVN) Reports Q2 Earnings: What Key Metrics Have to Say

August 5, 2026 | zacks.com

LivaNova PLC (LIVN) Hits Fresh High: Is There Still Room to Run?

August 5, 2026 | zacks.com

LivaNova: Q2 Earnings Snapshot

August 5, 2026 | finance.yahoo.com

LivaNova exceeds second-quarter forecasts and increases 2026 outlook

August 5, 2026 | msn.com

LivaNova (LIVN) Q2 Earnings and Revenues Beat Estimates

August 5, 2026 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

IART, HAE, LIVN, and ITGR Company Descriptions

Haemonetics NYSE:HAE

$103.00 +0.08 (+0.08%)

Closing price 09/4/2026 03:58 PM Eastern

Extended Trading

$102.88 -0.11 (-0.11%)

As of 05:04 AM Eastern

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Integra LifeSciences NASDAQ:IART

$16.72 0.00 (0.00%)

Closing price 09/4/2026 04:00 PM Eastern

Extended Trading

$16.55 -0.17 (-1.02%)

As of 04:09 AM Eastern

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Integer NYSE:ITGR

$126.40 -0.10 (-0.08%)

Closing price 09/4/2026 03:58 PM Eastern

Extended Trading

$126.37 -0.03 (-0.03%)

As of 04:17 AM Eastern

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

LivaNova NASDAQ:LIVN

$81.92 0.00 (0.00%)

Closing price 09/4/2026 04:00 PM Eastern

Extended Trading

$81.40 -0.52 (-0.63%)

As of 05:23 AM Eastern

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest IART, HAE, LIVN, and ITGR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest IART, HAE, LIVN, and ITGR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

IART, HAE, LIVN, and ITGR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

IART, HAE, LIVN, and ITGR Company Descriptions

Haemonetics NYSE:HAE

Integra LifeSciences NASDAQ:IART

Integer NYSE:ITGR

LivaNova NASDAQ:LIVN

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest IART, HAE, LIVN, and ITGR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest IART, HAE, LIVN, and ITGR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

IART, HAE, LIVN, and ITGR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

IART, HAE, LIVN, and ITGR Company Descriptions

Haemonetics NYSE:HAE

Integra LifeSciences NASDAQ:IART

Integer NYSE:ITGR

LivaNova NASDAQ:LIVN

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools